Sequana Medical Plans Summer EU Launch For Fluid Management Device
This article was originally published in The Gray Sheet
Executive SummarySequana Medical anticipates a European commercial launch this summer for its ALFApump system, a battery-powered implantable device designed to safely remove excess fluid from the abdomen in patients with liver disease.
You may also be interested in...
With positive data from two Phase III trials, Incyte hopes to file an NDA this year for topical Jakafi in mild-to-moderate AD.